CarbonSilicon AI

CarbonSilicon AI is a technology service provider specializing in intelligent drug research and development. It utilizes artificial intelligence to offer an integrated platform for small molecule candidate drug R&D, providing services such as drug design, virtual screening, and drug-likeness prediction. Focusing on novel drug development, CarbonSilicon AI aims to become the artificial intelligence infrastructure and service provider in this field. The company seeks to deeply integrate advanced life sciences with information technologies like artificial intelligence, driving progress through AI, physical computing, and automated hardware and software technologies. By enhancing capabilities in data production, data management, and AI modeling of data within the new drug R&D sector, the company strives to digitize and intelligize every aspect of the process, addressing key challenges in drug discovery.